GlassScriptPhysician profile
Jeffrey V Fowler
NPI 1215992359
$11,886.86
in general payments reported to CMS, 2019-2025
17 companies · $1,525 in 2025
The $1,525 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $774 · 2020: $151 · 2021: $285 · 2022: $30.61 · 2023: $4,650 · 2024: $4,472 · 2025: $1,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,500 · Travel and Lodging: $2,285 · Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,500.00 |
| Travel and Lodging | $2,285.35 |
| Food and Beverage | $861.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $7,500.00 | 2023-2025 | Carto 3 |
| Abbott Laboratories | $2,602.03 | 2019-2024 | Aveir, Jot Dx |
| Biosense Webster, INC. | $681.89 | 2019-2024 | Carto 3, Smartablatetm System Rf Generator |
| Boston Scientific Corporation | $474.73 | 2019-2025 | Farapulse, Watchman Flx |
| Medtronic, INC. | $197.46 | 2022-2025 | Affera Mapping System, Arctic Front Advance |
| Novartis Pharmaceuticals Corporation | $148.63 | 2019 | |
| Medtronic Vascular, INC. | $52.65 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $35.43 | 2024-2025 | Farxiga |
| Cardiva Medical, INC. | $28.24 | 2020 | |
| Cardiovascular Systems INC. | $25.85 | 2020 | |
| Amgen INC. | $24.16 | 2025 | Repatha |
| Pfizer INC. | $23.81 | 2023 | |
| Novo Nordisk INC | $22.26 | 2024 | Wegovy |
| Actelion Pharmaceuticals US, INC. | $20.90 | 2025 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $18.01 | 2025 | Verquvo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $17.58 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.23 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.